Pancreatic Cancer Research

ResearcherMemorial Sloan Kettering Cancer CenterActive in the last 2 years

Yi Zhong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4730-5077; OpenAlex author ID A5040011658. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
45
Papers, trials and grants by year

2011: 1 paper · 2012: 1 paper · 2013: none · 2014: 2 papers · 2015: none · 2016: none · 2017: 2 papers · 2018: none · 2019: 2 papers · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 10

  1. Reversible chemoresistance of pancreatic cancer grown as spheroids. Co-author DOI 10.1080/1120009x.2024.2402177↗
  2. A unifying paradigm for transcriptional heterogeneity and squamous features in pancreatic ductal adenocarcinoma. Co-author DOI 10.1038/s43018-019-0010-1↗
  3. Characterization of genetic subclonal evolution in pancreatic cancer mouse models. First author DOI 10.1038/s41467-019-13100-w↗
  4. The Genetic Basis of Transcriptional and Spatial Heterogeneity of Squamous Features in Pancreatic Ductal Adenocarcinoma Co-author DOI 10.1101/548354↗
  5. Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis. Co-author DOI 10.1038/ng.3753↗
  6. Mutant p53 Together with TGFβ Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer. Co-author DOI 10.1158/1078-0432.ccr-15-1615↗
  7. Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics. First author DOI 10.1074/mcp.m114.038547↗
  8. Functional p38 MAPK identified by biomarker profiling of pancreatic cancer restrains growth through JNK inhibition and correlates with improved survival. Co-author DOI 10.1158/1078-0432.ccr-13-2823↗
  9. Clinical significance of the genetic landscape of pancreatic cancer and implications for identification of potential long-term survivors. Co-author DOI 10.1158/1078-0432.ccr-12-1215↗
  10. GATA6 activates Wnt signaling in pancreatic cancer by negatively regulating the Wnt antagonist Dickkopf-1. Co-author DOI 10.1371/journal.pone.0022129↗

Closest collaborators

The 25 strongest of 45 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Christine A. Iacobuzio–Donahue · 9 shared papers, 2011–2020 · strength 0.48
  2. Ralph H. Hruban MD · 5 shared papers, 2012–2025 · strength 0.42
  3. Alvin P. Makohon-Moore · 5 shared papers, 2017–2020 · strength 0.36
  4. Christopher Lee Wolfgang · 3 shared papers, 2012–2025 · strength 0.27
  5. Michael Goggins · 2 shared papers, 2014–2025 · strength 0.25
  6. Yoshihisa Matsushita · 1 shared paper, 2025 · strength 0.21
  7. Alexis L. Norris · 1 shared paper, 2025 · strength 0.21
  8. Asma Begum · 1 shared paper, 2025 · strength 0.21
  9. Zeshaan A. Rasheed · 1 shared paper, 2025 · strength 0.21
  10. James R. Eshleman · 1 shared paper, 2025 · strength 0.21
  11. Zachary A. Kohutek · 3 shared papers, 2017–2020 · strength 0.21
  12. Olca Baştürk · 2 shared papers, 2019–2020 · strength 0.15
  13. Hitomi Sakamoto · 2 shared papers, 2019–2020 · strength 0.15
  14. Akimasa Hayashi · 2 shared papers, 2019–2020 · strength 0.15
  15. Marc A. Attiyeh · 2 shared papers, 2019–2020 · strength 0.15
  16. Jungeui Hong · 2 shared papers, 2019–2020 · strength 0.15
  17. Laura DeLong Wood · 2 shared papers, 2019–2020 · strength 0.15
  18. Noushin Niknafs · 1 shared paper, 2019 · strength 0.10
  19. Rachel Karchin · 1 shared paper, 2019 · strength 0.10
  20. Yoshiki Naito · 3 shared papers, 2011–2014 · strength 0.09
  21. Shinichi Yachida · 3 shared papers, 2011–2014 · strength 0.08
  22. Eileen Mary O'Reilly · 1 shared paper, 2020 · strength 0.08
  23. Joseph M. Herman · 2 shared papers, 2012–2014 · strength 0.07
  24. Martin C. Whittle · 1 shared paper, 2017 · strength 0.06
  25. Brian T. Herbst · 1 shared paper, 2017 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.